The optimization of recombinant antibody production in Chinese Hamster Ovary (CHO-K1) cells is a crucial aspect of biopharmaceutical development. To maximize efficacy, various methods are employed, including genetic engineering of the host Antibody Expression cells and optimization of culture conditions. Furthermore, implementation of advanced fe